UiPath Inc.
First established in Bucharest, Romania in 2005, UiPath was incorporated in Delaware in 2015 as a company principally focused on building and managing automations, starting with computer vision technology and user interface automations in our initial RPA offering, which remains the foundation of our platform today. Over the course of the past several years, we have followed a strategy of levera…
$14.05
+$0.33 (+2.44%)
EOD Oct 22, 2026
Operating margin is thin at 3.52%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue up 12.7% YoY with margins expanding 14.9pp.
Even for strong businesses, today's 21x P/E means the stock needs to keep delivering. There's no margin of safety if growth disappoints.
21.0x earnings, 20.2x FCF. Valuation is in a reasonable range. The main question is whether the business can re-accelerate or if current trajectory is already priced in.
Price History
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$1.72B
▲ +12.7% YoY
Net Income (TTM)
$362M
▲ +483.1% YoY
Op. Margin
8.89%
▲ +14.9pp YoY
ROIC
5.91%
▲ +8.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$363M
▲ +15.2% YoY
Op. Cash Flow (TTM)
$373M
▲ +15.8% YoY
Net Debt
-$1.20B
Net Cash Position
Cash & Equiv.
$1.28B
5Y CAGR: +21.5%
5Y CAGR: +66.9%
Continue Research
SourceComputed from the 10-Q filed 8 Sept 2026, covering the period ending 31 Jul 2026, as reported to the SEC. Data last refreshed 9 Sept 2026. How this is calculated.
Price from market data, last close as of 22 Oct 2026. Fiscal year ends Jan. Sector medians are approximate S&P 500 benchmarks and update periodically.
Is UiPath (PATH) overvalued?
At a P/E of 21.0 and a price-to-free-cash-flow of 20.2, UiPath (PATH) trades below a two-stage DCF intrinsic value of about $19.17 per share, so at $14.05 the stock looks undervalued (36.5% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, UiPath scores 81/100 on Intrinsiqq's quality scorecard (a high-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology, or see how the market compares in our US profitability statistics. This is analysis, not investment advice.
Frequently asked
What is UiPath's fair value?+
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $19.17 per share for PATH, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $14.38. At today's $14.05, that puts the stock about 36.5% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Is UiPath a high-quality business?+
UiPath scores 81 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a high-quality business on these measures. Recent fundamentals include a 8.9% operating margin and a 5.9% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Is UiPath a good stock to buy right now?+
That depends on valuation and quality together, not either alone. PATH currently trades below its estimated intrinsic value and scores 81/100 on quality (high-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.
Related stocks: Services-Prepackaged Software
Spot a number that looks wrong? Check it in PATH's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing PATH
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.